Inventor · disambiguated record
Ning Shen
Also filed as: SHEN NING
6 granted patents·6 pending applications·12 citations·filing 2012–2023
75Inventor score
Files withFULCRUM THERAPEUTICS INC7BEIJING IMMUPEUTICS MEDICINE TECH LIMITED1MA TAO1SHANGHAI HAIHE PHARMACEUTICAL CO LTD1SHANGHAI SVM MEDICAL TECH CO LTD1
Top patents by PatentIndex Score
12 records- 0188US10342786B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·4 cites·19 claims
- 0286US10537560B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·4 cites·28 claims
- 0377US2023257743A1Use of p38 inhibitors to reduce expression of dux4FULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0475US9453062B2Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereofMA TAO·Filed 2012·Granted Sep 27, 2016·4 cites·22 claims
- 0575US2022282254A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0672US2022133704A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0770US11479770B2Use of p38 inhibitors to reduce expression of DUX4FULCRUM THERAPEUTICS INC·Filed 2018·Granted Oct 25, 2022·0 cites·8 claims
- 0868US2024120026A1Method and device for extracting somatic mutations from single-cell transcriptome sequencing dataUNIV ZHEJIANG·Filed 2023·Application pending·0 cites
- 0967US11291659B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·0 cites·15 claims
- 1050US2025391530A1A method and system of mechanical ventilation therapy data managementSHANGHAI SVM MEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1148US2024027471A1Markers for predicting coronavirus disease 2019 (covid-19) immune checkpoint storm, application and kit thereofBEIJING IMMUPEUTICS MEDICINE TECH LIMITED·Filed 2021·Application pending·0 cites
- 1246US11465984B2Compound having ERK kinase inhibitory activity and use thereofSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 11, 2022·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Ning Shen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →